DeDora Capital Inc. Sells 460 Shares of The Procter & Gamble Company (NYSE:PG)

DeDora Capital Inc. reduced its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 3.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,569 shares of the company’s stock after selling 460 shares during the quarter. DeDora Capital Inc.’s holdings in Procter & Gamble were worth $2,039,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in the stock. Wellington Management Group LLP raised its holdings in Procter & Gamble by 9.4% in the 3rd quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company’s stock worth $5,193,916,000 after acquiring an additional 3,047,557 shares during the last quarter. Northern Trust Corp raised its stake in Procter & Gamble by 2.3% during the 3rd quarter. Northern Trust Corp now owns 29,313,150 shares of the company’s stock valued at $4,275,616,000 after buying an additional 670,862 shares during the last quarter. Norges Bank purchased a new stake in Procter & Gamble during the 4th quarter valued at $3,956,117,000. Charles Schwab Investment Management Inc. raised its stake in Procter & Gamble by 1.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 16,209,425 shares of the company’s stock valued at $2,336,552,000 after buying an additional 206,165 shares during the last quarter. Finally, Royal Bank of Canada raised its stake in Procter & Gamble by 3.2% during the 3rd quarter. Royal Bank of Canada now owns 11,170,305 shares of the company’s stock valued at $1,629,299,000 after buying an additional 346,925 shares during the last quarter. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Price Performance

Shares of PG traded up $0.62 during midday trading on Friday, hitting $164.46. 5,581,692 shares of the company traded hands, compared to its average volume of 6,941,715. The firm has a 50 day moving average of $160.01 and a 200-day moving average of $154.17. The Procter & Gamble Company has a 52 week low of $141.45 and a 52 week high of $164.71. The stock has a market cap of $388.15 billion, a price-to-earnings ratio of 26.87, a PEG ratio of 3.33 and a beta of 0.43. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.48 and a current ratio of 0.69.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Friday, April 19th. The company reported $1.52 EPS for the quarter, beating the consensus estimate of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The business had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.43 billion. During the same quarter in the prior year, the firm earned $1.37 EPS. The business’s revenue was up .6% on a year-over-year basis. On average, analysts forecast that The Procter & Gamble Company will post 6.55 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.45%. The ex-dividend date is Thursday, April 18th. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio is 65.85%.

Insider Buying and Selling at Procter & Gamble

In other news, insider Susan Street Whaley sold 3,865 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $160.60, for a total transaction of $620,719.00. Following the sale, the insider now directly owns 11,886 shares in the company, valued at approximately $1,908,891.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, insider Susan Street Whaley sold 3,865 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $160.60, for a total transaction of $620,719.00. Following the sale, the insider now directly owns 11,886 shares in the company, valued at approximately $1,908,891.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Gary A. Coombe sold 22,000 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the sale, the chief executive officer now owns 36,845 shares in the company, valued at $5,943,835.40. The disclosure for this sale can be found here. Insiders sold 86,865 shares of company stock valued at $14,059,180 in the last 90 days. Insiders own 0.17% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have weighed in on PG. Raymond James boosted their target price on shares of Procter & Gamble from $170.00 to $175.00 and gave the company an “outperform” rating in a research note on Wednesday, January 24th. Deutsche Bank Aktiengesellschaft reduced their price objective on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating for the company in a research note on Monday, April 22nd. Stifel Nicolaus upped their price objective on Procter & Gamble from $155.00 to $157.00 and gave the stock a “hold” rating in a research note on Wednesday, January 24th. JPMorgan Chase & Co. reduced their price objective on Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating for the company in a research note on Thursday, January 18th. Finally, Royal Bank of Canada upped their price objective on Procter & Gamble from $156.00 to $157.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 24th. Seven research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $169.76.

Get Our Latest Research Report on PG

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.